Ischaemic events are rare, and the prevalence of hypertension is not high in Japanese adults with haemophilia: First multicentre study in Asia.


Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 21 12 2018
revised: 25 02 2019
accepted: 13 03 2019
pubmed: 3 5 2019
medline: 19 12 2019
entrez: 3 5 2019
Statut: ppublish

Résumé

With the increasing life expectancy of patients with haemophilia (PWH), the number of PWH with age-related comorbidities, such as ischaemic events, is increasing. We conducted this multicentre observational study to identify the risk factors for major ischaemic events in PWH. This study was the first multicentre observational study, conducted with the participation of five haemophilia treatment centres in Japan, conducted in ≥30-year-old adult PWH. The latest data recorded in the medical charts between 1 January and 31 December 2016 were reviewed. Healthcare data collected from the National Health and Nutrition Survey were used as the control data. Data of a total of 711 patients were collected. Only two PWH (0.3%) had a history of ischaemic events. Age-adjusted analysis indicated that the prevalence of hypertension defined as a blood pressure of 140/90 mm Hg or over was similar in the PWH to that in the males of the general population. However, when hypertension was defined more strictly (≥130/85 mm Hg), the prevalence was significantly lower in PWH than in the general male population. The hypertension in PWH was associated with the age, BMI, CKD, HIV infection and inhibitors. In particular, the odds ratio for the presence of inhibitors was high (odds ratio = 7.529). Whether the present results can be attributed to Japanese ethnicity or to the presence of haemophilia per se remains uncertain. We propose to initiate a prospective study for further investigation.

Identifiants

pubmed: 31045306
doi: 10.1111/hae.13749
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e223-e230

Informations de copyright

© 2019 John Wiley & Sons Ltd.

Auteurs

Azusa Nagao (A)

Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan.

Nobuaki Suzuki (N)

Department of Transfusion Medicine, Nagoya University Hospital, Aichi, Japan.

Hideyuki Takedani (H)

Department of Joint Surgery, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Naoya Yamasaki (N)

Division of Blood Transfusion, Hiroshima University hospital, Hiroshima, Japan.

Yushi Chikasawa (Y)

Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.

Akihiro Sawada (A)

Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Takeshi Kanematsu (T)

Department of Clinical Laboratory, Nagoya University Hospital, Aichi, Japan.

Masanori Nojima (M)

Center for Translational Research, The Institute of Medical Science Hospital, The University of Tokyo, Tokyo, Japan.

Satoshi Higasa (S)

Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

Kagehiro Amano (K)

Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
Department of Molecular Genetics of Coagulation Disorders, Tokyo Medical University, Tokyo, Japan.

Katsuyuki Fukutake (K)

Department of Laboratory Medicine, Tokyo Medical University, Tokyo, Japan.
Department of Molecular Genetics of Coagulation Disorders, Tokyo Medical University, Tokyo, Japan.

Teruhisa Fujii (T)

Division of Blood Transfusion, Hiroshima University hospital, Hiroshima, Japan.

Tadashi Matsushita (T)

Department of Transfusion Medicine, Nagoya University Hospital, Aichi, Japan.

Takashi Suzuki (T)

Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH